Forvia (FRVIA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Organic sales grew 2.7% year-over-year in H1 2024, outperforming the market by 290 basis points, with outperformance of 460 basis points excluding geographic mix, and strong order intake of €15 billion, 40% from Asia.
Operating margin improved by 20 basis points to 5.2% of sales, despite a one-off €47 million cost in North America Interiors.
Net income was €5 million, impacted by higher restructuring and non-recurring supplier costs, but offset by capital gains from disposals.
Net cash flow increased 16% year-over-year to €201 million, reflecting strong cash management and asset disposals.
Deleveraging remains a top priority, with net debt/Adjusted EBITDA reduced to 2.0x and available liquidity of €6.2 billion.
Financial highlights
H1 2024 sales at €13.5 billion, up 2.7% organically but down 0.6% reported due to currency and scope effects.
Operating income was €700 million (5.2% of sales), up 20 basis points year-over-year; adjusted EBITDA margin at 12.1% (+30bps year-over-year).
Net cash flow was €201 million, up 16% year-over-year, with improved quality and sustainability.
CapEx was €419 million (3.1% of sales), down from €457.7 million; inventories reduced by €119 million.
Net financial cost in P&L expected below €500 million for the full year.
Outlook and guidance
FY 2024 sales and operating margin expected at the lower end of initial ranges: €27.5–28.5 billion sales, 5.6–6.4% margin.
Net cash flow target at least €649 million; leverage ratio ≤1.9x.
2025 sales ambition revised to €28–28.5 billion due to currency and market conditions, with strong margin and cash flow growth expected; POWER25 target of net debt/EBITDA <1.5x by end-2025 reaffirmed.
H2 2024 expected to see higher volumes, margin improvement, and normalization of one-off costs.
Latest events from Forvia
- 2024 outlook cut; accelerated cost and China growth actions target stronger 2025 results.FRVIA
Guidance10 Mar 2026 - Margin gains, strong cash flow, and portfolio reshaping set the stage for future growth.FRVIA
Q4 2025 & CMD24 Feb 2026 - Operating margin and cash flow rose, guidance confirmed despite SYMBIO-related net loss.FRVIA
Q2 20253 Feb 2026 - Q3 sales outperformed the market by 420bps, with strong order intake and margin focus.FRVIA
Q3 202419 Jan 2026 - Q1 2025 sales up 2.6% to €6.7bn, 2025 guidance confirmed amid market volatility.FRVIA
Q1 202525 Dec 2025 - Resilient 2024 results, strong cash flow, and further deleveraging targeted for 2025.FRVIA
Q4 202418 Dec 2025 - Resilient results, new CEO, and strategic focus on sustainability and deleveraging highlighted.FRVIA
AGM 202520 Nov 2025 - Stable Q3 sales and strong cost discipline support confirmed 2025 guidance amid mixed segment trends.FRVIA
Q3 202520 Oct 2025